Table 2.
Scenario | Time to diagnosis (mean) | Time to linkage to care (mean) | Loss to follow-up rate (%/y) | Treatment eligibility | Treatment rate among eligible PWID | %SVR |
---|---|---|---|---|---|---|
1 (reference) | 2 y | 1.7 y | 10.2%/y | F0 → F4 | 5%/y | 81% |
2 | 0.5 y | 1.7 y | 10.2%/y | F0 → F4 | 5%/y | 81% |
3 | 2 y | 0.5y | 5%/y | F0 → F4 | 5%/y | 81% |
4 | 2 y | 1.7 y | 10.2%/y | F0 → F4 | 5%/y | 90% |
5 | 2 y | 1.7 y | 10.2%/y | F0 → F4 | 10%/y | 81% |
6 | 2 y | 1.7 y | 10.2%/y | F0 → F4 | 20%/y | 81% |
7 | 0.5 y | 0.5 y | 5%/y | F0 → F4 | 20%/y | 90% |
8 | 0.5 y | 0.5 y | 5%/y | F2 → F4 | 100%/y | 90% |
PWID People who inject drugs, SVR sustained virological response